Login +0086-27-65522453 sales@sun-shinechem.com

BMS-582949 Catalog No : 16062903

Chemical Information

Product NameBMS-582949
Iupac Chemical Name4-((5-(cyclopropylcarbamoyl)-2-methylphenyl)amino)-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide 
SynonymsBMS-582949; BMS 582949; 
Molecular FormulaC22H26N6O2 
Molecular Weight406.49 
SmileC1(CC1)NC(=O)C=1C=CC(=C(C1)NC1=NC=NN2C1=C(C(=C2)C(=O)NCCC)C)C
InChiKeyGDTQLZHHDRRBEB-UHFFFAOYSA-N
InChiInChI=1S/C22H26N6O2/c1-4-9-23-22(30)17-11-28-19(14(17)3)20(24-12-25-28)27-18-10-15(6-5-13(18)2)21(29)26-16-7-8-16/h5-6,10-12,16H,4,7-9H2,1-3H3,(H,23,30)(H,26,29)(H,24,25,27)
Cas623152-17-0

Technical Data

AppearanceSolid powder 
Purity98% by HPLC 
SolubilitySoluble in DMSO 
Storage-20 ºC for 3 years 
Shipping ConditionShipped under ambient temperature 
Quality control

Description

BMS-582949 is a potent and selective P38 mitogen-activated protein kinase (P38 MAPK) inhibitor. BMS-582949 is currently under Phase II clinical trials for the treatment of inflammatory diseases. One clinical study showed that, in stable atherosclerosis, 12 weeks of treatment with BMS-582949 did not reduce arterial inflammation or hs-CRP compared to placebo, whereas intensification of statin therapy significantly decreased arterial inflammation. p38 MAP kinase plays a crucial role in regulating the biosynthesis of many inflammatory cytokines including TNF and IL-1 

Chemical Structure

16062903 - BMS-582949 | CAS 623152-17-0

Package

SizePrice
Login to get price

Quick Order

Change

Contact Us